Red flags / Going concern
CytoSorbents says cash and debt terms raise substantial doubt about its going concern status
The 10-Q states that as of September 30, 2026, CytoSorbents held about $5.7 million in cash and restricted cash, of which $4.2 million was unrestricted and available to fund operations. Management concludes that these balances, together with historical and expected cash use, the Strategic Workforce and Cost Reduction Plan and the Amended Loan and Security Agreement, raise substantial doubt about its ability to continue as a going concern within twelve months. Such a disclosure matters for investors because it signals the company may need to raise additional capital or restructure its debt, with dilution or financing terms as possible outcomes.
“These cash and restricted cash balances considered with the Company's historical and expected future cash used in operations, notwithstanding the Company's Strategic Workforce and Cost Reduction Plan (see Note 11, "Restructuring") and the impact of the Amended Loan and Security Agreement (see Note 6, "Long-Term Debt") raises substantial doubt about the Company's ability to continue as a going concern within twelve months after the date that the accompanying condensed consolidated financial statements are issued.”
What the stock did
From the last close before the filing was public. Market cap now: $13M.
10-K or 10-Q says there is substantial doubt the company can keep operating. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.
Other flags on CTSO
| Filed | Stock | Flag | What the filing says | Mkt cap | 5 days | 20 days |
|---|---|---|---|---|---|---|
| Nov 20, 8:58 AM ET | CTSO Cytosorbents Corporation | Dilution ElevatedForm 424B5 | CytoSorbents sells 855,637 shares and pre-funded warrants in $3.5 million registered direct offering | $13M | - | - |
| Nov 17, 6:28 AM ET | CTSO Cytosorbents Corporation | Late filing SevereForm NT 10-Q | CytoSorbents delays 10-Q filing over review of foreign currency exchange gains and losses | $13M | - | - |